A study to see effects of radiation alone and radiation with concurrent chemotherapy for advanced squamous cell carcinoma of the head and neck

نویسنده

  • Hai MA
چکیده

Aim : To observe the responses of radiation with concurrent chemo-radiation and radiation alone at the primary tumour sites and metastatic neck nodes of patients with head and neck cancers weekly during treatment, after completion of treatment and at 6 weeks interval after treatment. Methods : Randomizes prospective study was carried out in the Department of Radiotherapy, Dhaka Medical College and Hospital, Dhaka during the period of July 2003 to June 2004. Patients with histologic and/or cytologic confirmation of the diagnosis of squamous cell carcinoma of head and neck without distance metastasis were included in this study. After proper evaluation Arm-A was treated by concurrent chemotherapy with Inj. Cisplatinum 75mg/m2 on Day-1, Day-21 and Day-42 and conventional radiotherapy with a total dose of 60 Gy in 30 fractions in 6 weeks. Arm-B was treated by conventional radiotherapy with the same dose as that of Arm-A. Every patient was evaluated by monitoring routinely to see the responses. All the resultant informations were kept preserved on a prescribed data sheet. These informations were than analyzed statistically and results were compiled accordingly. Result : Out of 28 patients in Arm-A, complete desirable response was observed in 19 cases and partial response in 9 cases, where as out of 30 patients in Arm-B it was 7 and 23 cases respectively. Conclusion : Concurrent chemo-radiation showed better response than radiation alone, though toxicities were little bit higher but it was acceptable and easily manageable.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Review on the Efficacy of Chemotherapy in Locally Advanced Head and Neck Cancers

Background and Aims: Chemotherapy is utilized as a part of combined-modality programs to achieve organ preservation and improve survival in patients with locally advanced head and neck cancer. Combinedmodality protocols can be used in three forms: a) neoadjuvant induction chemotherapy before definitive surgery or radiotherapy; b) concomitant chemoradiotherapy; and c) sequential therapy consisti...

متن کامل

Survival Rate of Patients with Squamous Cell Carcinoma of Larynx Undergoing Nonsurgical Treatments and Radiotherapy, From 2003 to 2015

Background:The incidence rate of head and neck cancer in the world is about 560,000 new cases a year. Larynx cancer is the most common malignancy in head and neck in Iran. The most common head and neck carcinoma is the malignancy of squamous epithelial cells. This study was conducted to determine the survival rate of patients undergoing nonsurgical treatment methods for larynge...

متن کامل

Primary Squamous Cell Carcinoma of the Thyroid Gland

Introduction: Primary squamous cell carcinoma (SCC) of the thyroid gland is one of the rarest types of all reported thyroid malignancies worldwide. It is very aggressive in nature and carries a poor prognosis. The surgical resection with adjuvant radiotherapy and chemotherapy is the most recommended treatment despite its poor reported outcome.  Case Report: A 74-year-old woman presented wit...

متن کامل

Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.

BACKGROUND Despite resection followed by adjuvant radiotherapy, high-risk cutaneous squamous cell carcinomas of the head and neck region (SCCHN) often recur. Because adjuvant concurrent chemoradiation reduces recurrence among high-risk mucosal SCCHN, we sought to understand its efficacy among high-risk cutaneous SCCHN. METHODS We conducted a retrospective cohort study of patients with cutaneo...

متن کامل

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

Recurrent and/or metastatic squamous cell carcinoma of the head and neck (HNSCC) continues to be a source of significant morbidity and mortality worldwide. Agents that target the epidermal growth factor receptor (EGFR) have demonstrated beneficial effects in this setting. Cetuximab, a monoclonal antibody against the EGFR, improves locoregional control and overall survival when used as a radiati...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013